Derepression of the Her-2 uORF is mediated by a novel post-transcriptional control mechanism in cancer cells
Anuradha Mehta(PTC Therapeutics (United States)), Stuart W. Peltz(PTC Therapeutics (United States))
Cited by 65
Related Papers
Small molecule splicing modifiers with systemic HTT-lowering activity
|Nature Communications|2021|85